Cutler Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-57
Closed 5388
2022
Q3
$0 Sell
57
-92
-62% -$1.76K ﹤0.01% 5641
2022
Q2
$2K Hold
149
﹤0.01% 4410
2022
Q1
$5K Hold
149
﹤0.01% 4195
2021
Q4
$5K Hold
149
﹤0.01% 4246
2021
Q3
$11K Sell
149
-129
-46% -$9.16K ﹤0.01% 3880
2021
Q2
$24K Buy
278
+243
+694% +$23.1K ﹤0.01% 3150
2021
Q1
$3K Hold
35
﹤0.01% 4792
2020
Q4
$1K Hold
35
﹤0.01% 4633
2020
Q3
$1K Hold
35
﹤0.01% 4500
2020
Q2
$2K Hold
35
﹤0.01% 3876
2020
Q1
$1K Hold
35
﹤0.01% 3841
2019
Q4
$3K Hold
35
﹤0.01% 3352
2019
Q3
$3K Hold
35
﹤0.01% 3385
2019
Q2
$10K Buy
35
+4
+13% +$1.41K ﹤0.01% 2704
2019
Q1
$14K Buy
31
+30
+3,000% +$11.7K ﹤0.01% 2298
2018
Q4
$0 Buy
+1
New +$239 ﹤0.01% 4707
2018
Q3
Sell
-9
Closed -$1K 4811
2018
Q2
$1K Hold
9
﹤0.01% 3995
2018
Q1
$1K Buy
9
+4
+80% +$783 ﹤0.01% 4210
2017
Q4
$1K Sell
5
-17
-77% -$3.54K ﹤0.01% 4634
2017
Q3
$4K Sell
22
-4
-15% -$736 ﹤0.01% 4658
2017
Q2
$2K Sell
26
-89
-77% -$14.1K ﹤0.01% 5649
2017
Q1
$34K Sell
115
-77
-40% -$22.7K ﹤0.01% 2777
2016
Q4
$69K Buy
192
+189
+6,300% +$70.4K ﹤0.01% 2252
2016
Q3
$1K Buy
+3
New +$1.05K ﹤0.01% 6353

Other funds holding CSCI

Cutler Group's CSCI Position: Q4 2022 in Review

Cutler Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2022, closing a stake of 57 shares.

Cutler Group first reported a position in CSCI in Q3 2016 and held it in 24 quarters. The position peaked at $69K in Q4 2016. 13 funds tracked by Wall St. Rank hold CSCI as of Q4 2022.

  • Cutler Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 57 COSCIENS Biopharma Inc. Common Stock shares in Q4 2022.
  • Cutler Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2016 and held it in 24 quarters.
  • Cutler Group's COSCIENS Biopharma Inc. Common Stock position peaked at $69K in Q4 2016.
  • 13 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.